The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana ...

Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.

Health insurance companies are counting on specialty pharmacy to invigorate their finances as other business lines face headwinds.

Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...

The third quarter of 2023 was another mixed bag for major insurers as they continue to grapple with significant headwinds. | ...

The courtship between insurance giants Cigna and Humana is just not meant to be, Cigna officials said Monday. Why it matters: ...

On Thursday, Cigna Corporation (NYSE:CI) reported third-quarter sales of $63.7 billion, up 30% year-over-year, beating the ...

Baxter covers the Healthcare sector, focusing on stocks such as Humana, CVS Health, and Centene. Cigna has an analyst consensus of Strong Buy, with a price target consensus of $400.11. CI market cap ...

but we expect potential legislation to be manageable for top-tier players like Cigna, CVS, and UnitedHealth. Medicare Advantage is currently facing many regulatory challenges under the Democratic ...

Three independent pharmacies have filed separate lawsuits accusing GoodRx, which markets a prescription drug discount card, of conspiring with several pharmacy benefit managers to fix ...

CVS Health Corp (NYSE:CVS) reported third-quarter sales of $95.43 billion, beating the consensus of $92.75 billion. Total ...